Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages

被引:55
作者
Itonaga, I
Sabokbar, A
Murray, DW
Athanasou, NA
机构
[1] Nuffield Orthopaed Ctr, Dept Pathol, Oxford OX3 7LD, England
[2] Univ Oxford, Nuffield Dept Orthopaed Surg, Oxford, England
关键词
D O I
10.1136/ard.59.1.26
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Osteoprotegerin ligand (OPGL) is a newly discovered molecule, which is expressed by osteoblasts/bone stromal cells. This ligand and M-CSF are now known to be essential for osteoclast differentiation from marrow and circulating precursors. This study examined whether OPGL and its soluble receptor osteoprotegerin (OPG), influenced osteoclast formation from human arthroplasty derived macrophages, to determine if the effects of OFGL and OPG on these cells could contribute to the osteolysis of aseptic loosening. Methods-OPGL (+/- dexamethasone/M-CSF) was added to cultures of macrophages isolated from the pseudomembrane of loosened hip arthroplasties incubated on glass coverslips and dentine slices. OPG was added to cocultures of arthroplasty derived macrophages and UMR106 osteoblast-like cells. Osteoclast differentiation in long term cultures was assessed by expression of macrophage (CD14) and osteoclast markers (tartrate resistant acid phosphatase (TRAP), vitronectin receptor (VNR) and lacunar resorption). Results-In the absence of osteoblastic cells, the addition of OPGL alone was sufficient to induce differentiation of macrophages (CD14(+), TRAP(-), VNR-) into TRAP(+) and VNR+ multinucleated cells, capable of extensive lacunar resorption. OPG was found to inhibit osteoclast formation by arthroplasty macrophages in a dose dependent manner. OPG (100 ng/ml) more than halved the formation of TRAP(+) and VNR+ cells and the extent of lacunar resorption in co-cultures of UMR106 cells and arthroplasty macrophages. Conclusions-This study has shown that macrophages, isolated from the pseudomembrane surrounding loose arthroplasty components, are capable of differentiating into osteoclastic bone resorbing cells and that OPGL is required for this to occur. OPG inhibits this process, most probably by interrupting the cell-cell interaction between osteoblasts and mononuclear phagocyte osteoclast precursors present in the pseudomembrane.
引用
收藏
页码:26 / 31
页数:6
相关论文
共 50 条
[1]  
AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7
[2]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[3]  
Andersson Goran, 1992, P55
[4]  
[Anonymous], LEUCOCYTE TYPING
[5]   IMMUNOPHENOTYPIC DIFFERENCES BETWEEN OSTEOCLASTS AND MACROPHAGE POLYKARYONS - IMMUNOHISTOLOGICAL DISTINCTION AND IMPLICATIONS FOR OSTEOCLAST ONTOGENY AND FUNCTION [J].
ATHANASOU, NA ;
QUINN, J .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (12) :997-1003
[6]   RESORPTION OF DENTIN BY ISOLATED OSTEOCLASTS INVITRO [J].
BOYDE, A ;
ALI, NN ;
JONES, SJ .
BRITISH DENTAL JOURNAL, 1984, 156 (06) :216-220
[7]   Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells [J].
Brändström, H ;
Jonsson, KB ;
Ohlsson, C ;
Vidal, O ;
Ljunghall, S ;
Ljunggren, Ö .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (02) :338-341
[8]   Tumor necrosis factor-α and -β upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells [J].
Brändström, H ;
Jonsson, KB ;
Vidal, O ;
Ljunghall, S ;
Ohlsson, C ;
Ljunggren, Ö .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (03) :454-457
[9]  
BULLOUGH PG, 1988, ORTHOP CLIN N AM, V19, P611
[10]   The human osteoclast precursor circulates in the monocyte fraction [J].
Fujikawa, Y ;
Quinn, JMW ;
Sabokbar, A ;
McGee, JO ;
Athanasou, NA .
ENDOCRINOLOGY, 1996, 137 (09) :4058-4060